Intravenous Prostacyclin in Acute Nonhemorrhagic Stroke

Completed

Phase 2 Results

Results

The placebo group tended to fare better throughout the study, with a significant difference in neurologic deficit score favoring the placebo group at Week 2 (p = 0.0048).